Press Releases

13 nov. 2025

IMPLANET signs partnership agreement with 8i Robotics Inc. for the clinical evaluation of a surgeon-supervised robotic system for spine surgery

Download

3 nov. 2025

IMPLANET announces the success of its capital increase

Download

9 oct. 2025

Launch of a Capital Increase with Shareholders’ Preferential Subscription Rights (PSR)

Download

7 oct. 2025

IMPLANET Reports Q3 2025 Revenue of €2.9 Million, Up +26%

Download

23 sept. 2025

IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot® Spine Surgery System

Download

16 sept. 2025

IMPLANET Announces First-Half 2025 Results

Download

15 juil. 2025

IMPLANET announces CFDA approval for its innovative JAZZ range in China

Download

8 juil. 2025

IMPLANET announces half-year revenue for 2025 up 41% to €5.8 million

Download

24 avr. 2025

IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics’ Next-Gen Robotic Solutions at AANS in Boston

Download

14 avr. 2025

Minutes of IMPLANET’s Annual General Meeting held on April 11, 2025

Download

9 avr. 2025

IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%

Download

4 mars 2025

IMPLANET reports its 2024 Full-Year Results

Download

14 janv. 2025

IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million

Download

5 déc. 2024

IMPLANET Announces Financing of €2 Million

Download

8 oct. 2024

IMPLANET announces revenue of €2.3 million as of September 30, 2024, 50% growth

Download

25 sept. 2024

elliquence and Implanet Form Partnership for US Distribution of Ultrasonic Bone Scalpel Olea in Endoscopic Spine Market

Download

19 sept. 2024

Implanet to Co-Exhibit Alongside 8i Robotics’ Next-Gen Robotic Solutions at NASS1 booth #2412 in Chicago

Download

10 sept. 2024

IMPLANET announces its 2024 half-year results

Download

9 juil. 2024

IMPLANET reports revenue of €4.1 million in the first half of 2024

Download

13 mai 2024

IMPLANET receives FDA clearance for its new hybrid fixation system Jazz Spinal System

Download

25 avr. 2024

Minutes of IMPLANET’s Ordinary General Meeting held on April 25, 2024

Download

9 avr. 2024

IMPLANET reports its 2024 First-Quarter Revenue

Download

6 mars 2024

IMPLANET reports its 2023 full-year results

Download

2 févr. 2024

Implanet announces the success of its capital increase

Download

25 janv. 2024

Implanet announces the appointment of Max W. Painter as Vice-President and General Manager of its US subsidiary

Download

15 janv. 2024

IMPLANET reports 2023 annual revenue of €7.4 million

Download

11 janv. 2024

IMPLANET announces its 2024 financial calendar

Download

4 janv. 2024

Launch of an issue of new shares with preferential subscription rights

Download

12 déc. 2023

IMPLANET announces the launch of its training program in advance of marketing its JAZZ® range in China

Download

11 déc. 2023

Validation by Sanyou Medical's Board of Directors of its commitment to subscribe up to €5 million to IMPLANET's planned capital increase

Download

16 nov. 2023

IMPLANET receives the approval of its shareholders for its planned capital increase

Download

31 oct. 2023

IMPLANET specifies the terms of its planned capital increase

Download

17 oct. 2023

IMPLANET announces its 3rd-quarter and 9-month revenue to September 30, 2023

Download

11 oct. 2023

IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue

Download

28 sept. 2023

IMPLANET signs an agreement with Sanyou Medical for a proposed capital increase with preferential subscription rights

Download

28 sept. 2023

IMPLANET publishes its 2023 half-year results

Download

11 juil. 2023

IMPLANET reports revenue of €4.3 million in the first half of 2023

Download

4 mai 2023

Minutes of Implanet’s Annual General Meeting held on May 3, 2023

Download

25 avr. 2023

IMPLANET reports its Q1 2023 revenue

Download

11 avr. 2023

IMPLANET receives FDA clearance for its Squale anterior cervical cage range

Download

7 mars 2023

IMPLANET reports its 2022 financial results

Download

24 janv. 2023

IMPLANET reports 2022 annual revenue of €8.0 million, up 31%

Download

14 déc. 2022

2023 Financial Calendar

Download

28 nov. 2022

IMPLANET signs an exclusive distribution contract for SMTP Technology Co.'s ultrasonic surgical scalpel in France

Download

16 nov. 2022

IMPLANET signs a distribution agreement with Sanyou Medical in China and a technological partnership for the development of a new product range

Download

26 oct. 2022

IMPLANET announces 9-month revenue of €6 million as of September 30, 2022, up +37%

Download

20 oct. 2022

Implanet announces the success of its capital increase

Download

28 sept. 2022

Press Releases

IMPLANET signs partnership agreement with 8i Robotics Inc. for the clinical evaluation of a surgeon-supervised robotic system for spine surgery

IMPLANET announces the success of its capital increase

Launch of a Capital Increase with Shareholders’ Preferential Subscription Rights (PSR)

IMPLANET Reports Q3 2025 Revenue of €2.9 Million, Up +26%

IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot® Spine Surgery System

IMPLANET Announces First-Half 2025 Results

IMPLANET announces CFDA approval for its innovative JAZZ range in China

IMPLANET announces half-year revenue for 2025 up 41% to €5.8 million

IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics’ Next-Gen Robotic Solutions at AANS in Boston

Minutes of IMPLANET’s Annual General Meeting held on April 11, 2025

IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%

IMPLANET reports its 2024 Full-Year Results

IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million

IMPLANET Announces Financing of €2 Million

IMPLANET announces revenue of €2.3 million as of September 30, 2024, 50% growth

elliquence and Implanet Form Partnership for US Distribution of Ultrasonic Bone Scalpel Olea in Endoscopic Spine Market

Implanet to Co-Exhibit Alongside 8i Robotics’ Next-Gen Robotic Solutions at NASS1 booth #2412 in Chicago

IMPLANET announces its 2024 half-year results

IMPLANET reports revenue of €4.1 million in the first half of 2024

IMPLANET receives FDA clearance for its new hybrid fixation system Jazz Spinal System

Minutes of IMPLANET’s Ordinary General Meeting held on April 25, 2024

IMPLANET reports its 2024 First-Quarter Revenue

IMPLANET reports its 2023 full-year results

Implanet announces the success of its capital increase

Implanet announces the appointment of Max W. Painter as Vice-President and General Manager of its US subsidiary

IMPLANET reports 2023 annual revenue of €7.4 million

IMPLANET announces its 2024 financial calendar

Launch of an issue of new shares with preferential subscription rights

IMPLANET announces the launch of its training program in advance of marketing its JAZZ® range in China

Validation by Sanyou Medical's Board of Directors of its commitment to subscribe up to €5 million to IMPLANET's planned capital increase

IMPLANET receives the approval of its shareholders for its planned capital increase

IMPLANET specifies the terms of its planned capital increase

IMPLANET announces its 3rd-quarter and 9-month revenue to September 30, 2023

IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue

IMPLANET signs an agreement with Sanyou Medical for a proposed capital increase with preferential subscription rights

IMPLANET publishes its 2023 half-year results

IMPLANET reports revenue of €4.3 million in the first half of 2023

Minutes of Implanet’s Annual General Meeting held on May 3, 2023

IMPLANET reports its Q1 2023 revenue

IMPLANET receives FDA clearance for its Squale anterior cervical cage range

IMPLANET reports its 2022 financial results

IMPLANET reports 2022 annual revenue of €8.0 million, up 31%

2023 Financial Calendar

IMPLANET signs an exclusive distribution contract for SMTP Technology Co.'s ultrasonic surgical scalpel in France

IMPLANET signs a distribution agreement with Sanyou Medical in China and a technological partnership for the development of a new product range

IMPLANET announces 9-month revenue of €6 million as of September 30, 2022, up +37%

Implanet announces the success of its capital increase

Launch of an issue of shares with warrants with preferential subscription rights

IMPLANET publishes its 2022 half-year results

Partnership with Sanyou Medical: conditions precedent fulfilled